Acadian Asset Management LLC lowered its position in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) by 54.4% during the second quarter, Holdings Channel reports. The firm owned 26,723 shares of the medical device company’s stock after selling 31,866 shares during the period. Acadian Asset Management LLC’s holdings in Cardiovascular Systems were worth $861,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP boosted its position in shares of Cardiovascular Systems by 10.8% in the first quarter. Wellington Management Group LLP now owns 2,772,835 shares of the medical device company’s stock worth $78,403,000 after buying an additional 269,425 shares during the period. Champlain Investment Partners LLC boosted its position in shares of Cardiovascular Systems by 5.4% in the first quarter. Champlain Investment Partners LLC now owns 1,742,285 shares of the medical device company’s stock worth $49,263,000 after buying an additional 89,010 shares during the period. Vanguard Group Inc. boosted its position in shares of Cardiovascular Systems by 22.7% in the first quarter. Vanguard Group Inc. now owns 1,656,356 shares of the medical device company’s stock worth $46,834,000 after buying an additional 305,953 shares during the period. Cortina Asset Management LLC purchased a new position in shares of Cardiovascular Systems during the first quarter worth approximately $24,329,000. Finally, First Manhattan Co. boosted its position in shares of Cardiovascular Systems by 8.0% in the first quarter. First Manhattan Co. now owns 764,200 shares of the medical device company’s stock worth $18,142,000 after buying an additional 56,700 shares during the period. Institutional investors own 75.15% of the company’s stock.

Shares of Cardiovascular Systems, Inc. (NASDAQ CSII) traded up 1.13% during trading on Friday, hitting $30.37. The stock had a trading volume of 88,299 shares. The stock has a 50-day moving average of $31.69 and a 200 day moving average of $29.54. The firm’s market cap is $994.04 million. Cardiovascular Systems, Inc. has a 12-month low of $21.29 and a 12-month high of $33.11.

Cardiovascular Systems (NASDAQ:CSII) last issued its earnings results on Wednesday, August 2nd. The medical device company reported $0.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.05) by $0.07. Cardiovascular Systems had a positive return on equity of 0.89% and a negative net margin of 0.87%. The company had revenue of $52.90 million during the quarter, compared to the consensus estimate of $51.98 million. During the same quarter in the prior year, the business earned ($0.15) earnings per share. The company’s revenue was up 9.1% compared to the same quarter last year. On average, analysts predict that Cardiovascular Systems, Inc. will post $0.04 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Sold by Acadian Asset Management LLC” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.watchlistnews.com/cardiovascular-systems-inc-nasdaqcsii-shares-sold-by-acadian-asset-management-llc/1473769.html.

Several brokerages have recently issued reports on CSII. Needham & Company LLC reiterated a “buy” rating and issued a $37.00 price objective (up previously from $32.00) on shares of Cardiovascular Systems in a research note on Friday, July 14th. Bank of America Corporation cut Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a research note on Wednesday, June 21st. BidaskClub cut Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. TheStreet upgraded Cardiovascular Systems from a “d” rating to a “c-” rating in a research note on Thursday, May 4th. Finally, Zacks Investment Research cut Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Friday, August 4th. Three analysts have rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $33.83.

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.